Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Enes Murat Atasoyu
36 years of experience
Clinic is certified :
Biological therapy in Turkey typically costs from AUD $7,688 to AUD $12,580. Prices vary based on the specific medication, treatment duration, and the underlying medical condition. In Australia, similar treatments often cost around AUD $12,580, meaning patients can achieve savings of approximately 39%. Standard packages often cover medical consultations, the biological agent, and interpreter services.
Bookimed Expert Insight: Choosing a multi-specialty centre provides superior value for complex biological treatments. Larger institutions like Anadolu Medical Center are affiliated with Johns Hopkins Hospital, providing international standards. Medipol Mega University Hospital uses advanced diagnostics to tailor protocols for over one million patients annually. These high volumes allow clinics to maintain competitive pricing while using the latest biological agents. Many top-tier Turkish hospitals hold JCI accreditation, ensuring quality systems meet rigorous international benchmarks.
| Turkey | Thailand | ||
| Biological therapy | from AUD $7,688 | from AUD $6,989 | from AUD $2,516 |
Associate Professor Omur Gokmen Sevindik brings expertise from the world-renowned Mayo Clinic to his role at Istanbul Florence Nightingale Hospital.
Professor Bülent Eser is a senior specialist in haematology and internal medicine at the Medical Park Antalya Hospital Complex.
Dr. Selman Dogan is a highly-rated orthopedic surgeon at Hisar Hospital Intercontinental in Istanbul. He specializes in hip and shoulder replacement and treats international patients. Dr. Dogan also manages complex spine and extremity trauma. He holds a degree from the Cerrahpasa School of Medicine. He completed his residency at Istanbul Umraniye Teaching Hospital.
Professor Savas Kansoy is a leading authority in paediatric stem cell therapies, having chaired the Regenerative Medicine and Stem Cell Commission at Ege University for a decade.
Istanbul and Ankara are Turkey's primary hubs for advanced biological and targeted treatments. Istanbul hosts the highest density of JCI-accredited facilities. They specialise in immunotherapy, CAR T-cell therapy, and molecular profiling. Meanwhile, Ankara serves as the research-heavy capital for clinical trials and complex medical oncology.
Bookimed Expert Insight: Istanbul clinics like Anadolu Medical Center are ideal for immediate access to drug-based immunotherapy. However, patients seeking clinical trials for next-generation antibodies should focus on Ankara. Data shows major research hospitals there, like Memorial Ankara, frequently participate in trials for lung cancer and complex solid tumours.
Patient Consensus: Patients travel to Turkey for specialist second opinions as much as treatment. Istanbul is the preferred base for its mix of private hospitals. However, the capital is recommended for trial enrolments.
Turkish hospitals are highly qualified to perform advanced biological therapy and immunotherapy. This includes checkpoint inhibitors like Keytruda. Leading centres hold JCI accreditation and follow international ESMO and ASCO protocols. Facilities such as Anadolu Medical Center maintain a strategic affiliation with Johns Hopkins Medicine. This ensures Western-level clinical standards for oncology.
Bookimed Expert Insight: Turkish university hospitals offer a distinct advantage for complex cases. They do this by combining cellular therapies with traditional oncology. Professor Dr Rafet Eren and other specialists work at Biruni University Hospital. They frequently integrate haploidentical transplants with biological treatments. This high-volume experience with blood disorders often exceeds what is available in standard private clinics.
Patient Consensus: Patients find that major private hospitals in Istanbul provide credible, standard-of-care immunotherapy. These hospitals offer specialist monitoring. They suggest choosing large, accredited institutions. At these institutions, oncologists provide written treatment plans and detailed drug regimens for home-country specialists.
Biological therapy packages in Turkey typically bundle monoclonal antibody or immunotherapy administration. They also include core diagnostics, specialist consultations, and VIP logistics. Most accredited hospitals include private airport transfers, multilingual patient coordinators, and initial pathology reviews. These are included in their standard international service agreements.
Bookimed Expert Insight: Clinics like Anadolu Medical Center or Hisar Hospital bundle coordination and transfers. However, medication costs often fluctuate. The most cost-effective approach is to request a drug-specific quote. Some Turkish centres offer significant discounts on biologics that aren't reflected in the base package price.
Patient Consensus: Patients find the bundled translation and transfer services in Turkey essential. They help navigate complex oncology appointments. Most suggest confirming if specific diagnostic imaging or maintenance doses are included before arriving.
Biological therapy, or immunotherapy, uses the body's immune system to identify and destroy cancer cells. In Turkey, specialists use checkpoint inhibitors like Keytruda and advanced CAR T-cell therapy. These treatments are provided at JCI-accredited centres for lung cancer, melanoma, and blood cancers through personalised infusion protocols.
Bookimed Expert Insight: Turkish oncology hubs like Anadolu Medical Center bridge the gap between Western standards and affordability through direct affiliations with top US hospitals like Johns Hopkins. While immunotherapy typically costs from $2,200 to $5,600 per cycle, patients access the same ESMO-compliant protocols used in Australia. They also save up to 73% on total treatment costs.
Patient Consensus: Many patients in Turkey experience significant tumour reduction when combining immunotherapy with chemotherapy. Patients should confirm drug names upfront. They should also arrange follow-up care for immune-related side effects before returning home.
Biological therapy in Turkey treats advanced cancers. These include non-small cell lung cancer, malignant melanoma, and colorectal cancer. Major JCI-accredited centres like Anadolu Medical Center and Memorial Şişli Hospital use immunotherapy, CAR T-cell therapy, and targeted agents. They treat blood disorders, urological tumours, and aggressive breast cancers.
Bookimed Expert Insight: Turkish oncology hubs often provide molecular genetic testing to match patients with specific biologics. This precision approach allows surgeons like Dr Abdullah Sakin at Medipol to use Keytruda. It targets tumours with specific biomarkers. This level of customisation is standard at Johns Hopkins-affiliated facilities in Istanbul.
Patient Consensus: Patients travel to Turkey for targeted immunotherapy when standard treatments leave residual disease. Many report significant tumour shrinkage in lung and colon cancer cases. They achieve this after combining biologics with traditional protocols.
Biological therapy packages in Turkey typically bundle specific drug administration with specialist consultations. They also include diagnostic imaging and local logistics. These oncology or autoimmune protocols cover initial specialist reviews. They also include baseline blood panels and outpatient infusion monitoring. Most packages also include VIP airport transfers and multi-lingual coordination for international patients.
Bookimed Expert Insight: Turkish centres like Hisar Hospital or Anadolu Medical Center often include HEPA-filtered rooms. They also include multi-lingual coordinators in their base price. For Australians, the A$13,600 domestic average drops to $2,200–$5,600 in Istanbul. This makes complex cellular therapies significantly more accessible without compromising on guidelines.
Patient Consensus: Clinics in Turkey arrange all transport from the airport to appointments. Patients suggest getting a written breakdown of hotel, medicine, and testing inclusions before travelling. Follow-up reviews are often handled via remote check-ins once back home.
The biological therapy evaluation process in Turkey requires a structured digital review by JCI-accredited hospitals. This review is done before patients travel. Patients submit medical records remotely. A multidisciplinary board then confirms candidacy for immunotherapy or targeted treatments. Specialists then issue a formal plan covering protocol, timelines, and costs.
Bookimed Expert Insight: Anadolu Medical Center stands out for its direct affiliation with Johns Hopkins Hospital. This affiliation allows Australian patients to access American-standard protocols for biological therapies. Such affiliations often mean the clinic handles complex cases that smaller facilities might refer elsewhere.
Patient Consensus: Contacting the hospital's international office directly allows all documents to be reviewed before patients leave Australia. Patients in Turkey appreciate the personal coordinators who manage everything from translations to doctor appointments.